InflaRx N.V. (IFRX)
NASDAQ·Healthcare·Biotechnology
$1.67
-0.60%
Mkt Cap $64.44M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$2.00
Range $2.00 – $2.00
Implied Upside
+20.1%
Consensus $2.00 vs current $1.67
NASDAQ·Healthcare·Biotechnology
$1.67
-0.60%
Mkt Cap $64.44M
No recent rating data.
Price Target (3 analysts)
$2.00
Range $2.00 – $2.00
+20.1%
Consensus $2.00 vs current $1.67